{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T22:06:37Z","timestamp":1772921197826,"version":"3.50.1"},"reference-count":12,"publisher":"Japanese Society of Internal Medicine","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,3,1]]},"DOI":"10.2169\/internalmedicine.5729-25","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T22:07:30Z","timestamp":1754518050000},"page":"708-714","source":"Crossref","is-referenced-by-count":0,"title":["Atypical Presentation of Intravascular Large B-cell Lymphoma After Treatment for Antineutrophil Cytoplasmic Antibody-associated Vasculitis"],"prefix":"10.2169","volume":"65","author":[{"given":"Seigi","family":"Oshima","sequence":"first","affiliation":[{"name":"Department of Hematology, Medical Research Institute Kitano Hospital, PIIF Tazuke-Kofukai, Japan"},{"name":"Department of Hematology, Kyoto University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhiro","family":"Shimada","sequence":"additional","affiliation":[{"name":"Department of Hematology, Medical Research Institute Kitano Hospital, PIIF Tazuke-Kofukai, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiro","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Department of Hematology, Medical Research Institute Kitano Hospital, PIIF Tazuke-Kofukai, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shungo","family":"Mochizuki","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Dialysis, Medical Research Institute Kitano Hospital, PIIF Tazuke-Kofukai, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yui","family":"Fukuda","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Dialysis, Medical Research Institute Kitano Hospital, PIIF Tazuke-Kofukai, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miho","family":"Miyauchi","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Dialysis, Medical Research Institute Kitano Hospital, PIIF Tazuke-Kofukai, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomomi","family":"Endo","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Dialysis, Medical Research Institute Kitano Hospital, PIIF Tazuke-Kofukai, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gen","family":"Honjo","sequence":"additional","affiliation":[{"name":"Department of Pathology, Medical Research Institute Kitano Hospital, PIIF Tazuke-Kofukai, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuo","family":"Tsukamoto","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Dialysis, Medical Research Institute Kitano Hospital, PIIF Tazuke-Kofukai, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyuki","family":"Kitano","sequence":"additional","affiliation":[{"name":"Department of Hematology, Medical Research Institute Kitano Hospital, PIIF Tazuke-Kofukai, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Ponzoni M, Campo E, Nakamura S. Intravascular large B-cell lymphoma: a chameleon with multiple faces and many masks. Blood 132: 1561-1567, 2018.","DOI":"10.1182\/blood-2017-04-737445"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Shimada K, Matsue K, Yamamoto K, et al. Retrospective analysis of intravascular large B-cell lymphoma treated with rituximab-containing chemotherapy as reported by the IVL study group in Japan. J Clin Oncol 26: 3189-3195, 2008.","DOI":"10.1200\/JCO.2007.15.4278"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Liu Z, Zhang Y, Zhu Y, Zhang W. Prognosis of intravascular large B cell lymphoma (IVLBCL): analysis of 182 patients from global case series. Cancer Manag Res 12: 10531-10540, 2020.","DOI":"10.2147\/CMAR.S267825"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Pankhurst T, Savage CO, Gordon C, Harper L. Malignancy is increased in ANCA-associated vasculitis. Rheumatology (Oxford) 43: 1532-1535, 2004.","DOI":"10.1093\/rheumatology\/keh374"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Folci M, Ramponi G, Shiffer D, Zumbo A, Agosti M, Brunetta E. ANCA-associated vasculitides and hematologic malignancies: lessons from the past and future perspectives. J Immunol Res 2019: 1732175, 2019.","DOI":"10.1155\/2019\/1732175"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Kidney Disease; Improving Global Outcomes (KDIGO) ANCA Vasculitis Work Group. KDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis. Kidney Int 105: S71-S116, 2024.","DOI":"10.1016\/j.kint.2023.10.008"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Jayne DRW, Merkel PA, Schall TJ, Bekker P; ADVOCATE Study Group. Avacopan for the treatment of ANCA-associated vasculitis. N Engl J Med 384: 599-609, 2021.","DOI":"10.1056\/NEJMoa2023386"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Walsh M, Merkel PA, Peh CA, et al.; PEXIVAS Investigators. Plasma exchange and glucocorticoids in severe ANCA-associated vasculitis. N Engl J Med 382: 622-631, 2020.","DOI":"10.1056\/NEJMc2004843"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Tsuda M, Nakashima Y, Ikeda M, et al. Intravascular large B-cell lymphoma complicated by anti-neutrophil cytoplasmic antibody-associated vasculitis that was successfully treated with rituximab-containing chemotherapy. J Clin Exp Hematop 55: 39-43, 2015.","DOI":"10.3960\/jslrt.55.39"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Shinkawa Y, Hatachi S, Yagita M. Intravascular large B-cell lymphoma with a high titer of proteinase-3-anti-neutrophil cytoplasmic antibody mimicking granulomatosis with polyangiitis. Mod Rheumatol 29: 195-197, 2019.","DOI":"10.1080\/14397595.2016.1205798"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Shimada K, Matsue K, Yamamoto K, et al. Retrospective analysis of intravascular large B-cell lymphoma treated with rituximab-containing chemotherapy as reported by the IVL study group in Japan. J Clin Oncol 26: 3189-3195, 2008.","DOI":"10.1200\/JCO.2007.15.4278"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Murakami J, Arita K, Wada A, et al. Serum soluble interleukin-2 receptor levels for screening for malignant lymphomas and differential diagnosis from other conditions. Mol Clin Oncol 11: 474-482, 2019.","DOI":"10.3892\/mco.2019.1922"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/5\/65_5729-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T03:45:43Z","timestamp":1772855143000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/5\/65_5729-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,1]]},"references-count":12,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5729-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,1]]},"article-number":"5729-25"}}